VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 300 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2017. The put-call ratio across all filers is 2.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,673,000 | +43.4% | 115,000 | -1.8% | 0.02% | +45.5% |
| Q1 2018 | $1,864,000 | -20.7% | 117,088 | +3.5% | 0.01% | -21.4% |
| Q4 2017 | $2,350,000 | +80.1% | 113,088 | +24.2% | 0.01% | +100.0% |
| Q3 2017 | $1,305,000 | +23.7% | 91,088 | +49.3% | 0.01% | +16.7% |
| Q2 2017 | $1,055,000 | +218.7% | 61,000 | +103.3% | 0.01% | +200.0% |
| Q1 2017 | $331,000 | -10.1% | 30,000 | +100.0% | 0.00% | 0.0% |
| Q3 2016 | $368,000 | +21.9% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $302,000 | -23.5% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $395,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |